|For further information:|
|Phone US: (732) 649-9961|
January 24, 2003
LSR ANNOUNCES RESIGNATION OF A DIRECTOR
New Jersey, January 24, 2003 – Life Sciences Research, Inc. ("LSR")
(OTCBB: LSRI) announced today the resignation of Mr. M. Faruque from its
Board of Directors.
Sciences Research, Inc. is a global Contract Research Organization
providing product development services to the pharmaceutical, agrochemical
and biotechnology industries.
LSR brings leading technology and capability to support its clients
in non-clinical safety testing of new compounds in early stage development
The purpose of this work is to identify risks to humans, animals or
the environment resulting from the use or manufacture of a wide range of
chemicals which are essential components of LSR's clients' products.
The Company's services are designed to meet the regulatory
requirements of governments around the world.
LSR operates research facilities in the United States (the
Princeton Research Center, New Jersey) and the United Kingdom (Huntingdon
and Eye, England).
This announcement contains statements that may be forward-looking as defined by the USA’s Private Securities Litigation Reform Act of 1995. These statements are based largely on LSR’s expectations and are subject to a number of risks and uncertainties, certain of which are beyond LSR’s control, as more fully described in LSR’s Registration Statement on Form S-1, dated July 12, 2002, and the Company’s Form 10-K for the fiscal year ended December 31, 2001, each as filed with the US Securities and Exchange Commission.